Table 1 Clinical characteristics of patients studied

Patients with simultaneous involvement by NLPHL and DLBCL

26

-

Patients with sequential involvement by NLPHL and DLBCL

7

-

Median patient age (range)

50 (19– 78)

69 (19– 93)

male gender (%)

85

100*

Biopsy site

- axillary

12 (36%)

4 (10%)

- cervical/ supraclavicular

9 (27%)

26 (63%)

- abdominal/ mesenteric LN /bowel

8 (24%)

5 (12%)

- inguinal

4 (12%)

1 (2%)

- mediastinal/ retroperitoneal

0

3 (7%)

- other

0

2 (5%)

Splenic involvement

30%

5%

Stage**

- I

2 (9%)

7 (17%)

- II

4 (18%)

12 (29%)

- III

6 (27%)

12 (29%)

- IV

10 (45%)

10 (24%)